Sarepta Therapeutics, Inc. ( SRPT ) reported results through week 144 from a phase IIb study (Study 202 a long …read more
Sarepta Plunges on Eteplirsen Study Results – Analyst Blog
- by Bob Mitchell
Sarepta Therapeutics, Inc. ( SRPT ) reported results through week 144 from a phase IIb study (Study 202 a long …read more